In the News

Dr. Francis Collins highlights the first trans-TARGET data publication in his Director’s blog Working Towards Greater Precision in Childhood Cancers. This study, published in …

The NCI Office of Cancer Genomics, along with Cancer Research UK, foundation Hubrecht Organoid Technology, and Wellcome Trust Sanger Institute, launched the Human Cancer Models Initiative (HCMI).…

The NCI’s Center for Cancer Genomics launches the Genomic Data Commons (GDC), a unified data sharing platform for the cancer research community. The mission of the GDC is to enable data sharing…

As part of the Vice President’s National Cancer Moonshot Initiative, the National Cancer Institute has launched an online engagement platform to enable the research community and the public to…

The ORFeome Collaboration (OC) is a team of academic and commercial entities which have generated the largest collection of clones containing verified open-reading frames (ORFs) of known human…

It is with great sadness and a profound sense of loss that OCG recognizes the untimely passing of Dr. Robert J. Arceci. Dr. Arceci was a co-Principal Investigator for the Acute Myeloid Leukemia (…

The CTD2 Dashboard hosts analyzed data and other evidence generated by the CTD2 Network. It is a web interface for the research community to browse and search …

The National Cancer Institute (NCI) has launched the Center for Cancer Genomics (CCG) website within www.cancer.gov to provide an overview of CCG programs, collaborative efforts, events, and more…

TARGET researchers molecularly characterized favorable histology Wilms tumor (FHWT), a pediatric renal cancer. Comprehensive genome and transcript analyses revealed single-nucleotide substitution/…

In a recent Cancer Discovery report, CTD2 researchers at the University of California in San Francisco developed a new quantitative chemical-genetic interaction mapping approach to evaluate drug…